Answers are grounded in this paper and cite their sources.
Retrospective study observes hemophagocytic lymphohistiocytosis in chronic granulomatous disease, highlighting treatment efficacy with antimicrobials, steroids, and intravenous immunoglobulin.
Hemophagocytic lymphohistiocytosis (HLH) is characterized by fever, cytopenias, splenomegaly, and hemophagocytosis by macrophages activated by high cytokine levels. Chronic granulomatous disease (CGD) is characterized by recurrent infections, hyperinflammation, and excessive cytokine release. This may predispose patients with CGD to developing HLH during an infection. We conducted a retrospective review of patients with CGD, treated at our institution between 1999 and 2008. Three out of 17 patients developed HLH. Patients with CGD may be at increased risk for developing HLH. Remission of HLH was achieved after treatment with antimicrobials, steroids, and intravenous immunoglobulin This approach to treatment appears to be effective.
No takes yet. Share an insight, caveat, or question.
Parekh et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: